Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2020
- Traction
- Plans to launch a series of clinical studies across the United States in 2025 to further validate its technology.
- Founders
- Josie Xu
- Company Description
- Diag-Nose.io is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions. Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model.
- Market
- Respiratory Care
- Location
-
Menlo Park,
California,
United States
- Coinvestors
- Breakthrough Victoria, Radar Ventures, Specialty Physician Associates, Carl Stubbings, Stephen Ho, Richard Lipscombe
Links